4 completed, 1 unknown. 2 Not applicable, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Immuno-Deficiency: new trials by email Literature Review of Immuno-Deficiency trials Research Report on Immuno-Deficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PREP (Pre-Exposure Prophylaxis) of COVID-19 Evusheld - Immuno-Deficiency, COVID-19 | Completed | Ghady Haidar | 138 | 2022-07-26 | 2024-07-15 | |
| Determination of Adequate Tuberculosis Regimen in Patients Hospitalized With HIV-associated Severe Immune Suppression Intensified TB treatment (initial phase), WHO standard TB treatment (initial phase) - Tuberculosis, HIV-1-infection | Phase 3 | Completed | ANRS, Emerging Infectious Diseases | 1330 | 2022-04-21 | 2025-12-22 |
| Preemptive Use of Convalescent Plasma for High-risk Patients With COVID-19 SARS-CoV-2 convalescent plasma - Covid19, Immuno-Deficiency | Phase 3 | Unknown | University Hospital, Geneva | 100 | 2021-04-08 | 2021-04-08 |
| Pediatric Intensive Care Unit and Primary Immune Deficiency Systematic screening of immune deficiency - Immuno-Deficiency | Not applicable | Completed | University Hospital, Caen | 90 | 2018-01-26 | 2022-11-29 |
| Effects of Immunonutrition on Biomarkers in Traumatic Brain Injury Neomune, Fresubin® HP energy - Traumatic Brain Injury, Immuno-Deficiency | Not applicable | Completed | University of Malaya | 36 | 2014-07-01 | 2017-05-30 |
COVID-19 (2) · Brain Injuries, Traumatic (1) · Frailty (1) · Tuberculosis (1)
Infections (3) · Coronaviridae Infections (2) · Coronavirus Infections (2) · Lung Diseases (2) · Nidovirales Infections (2) · Pneumonia (2) · Pneumonia, Viral (2) · RNA Virus Infections (2) · Respiratory Tract Diseases (2) · Respiratory Tract Infections (2) · Virus Diseases (2) · Actinomycetales Infections (1) · Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Brain Diseases (1)
COVID-19 Serotherapy (1) · cilgavimab and tixagevimab drug combination (1)
ANRS, Emerging Infectious Diseases (1) · Ghady Haidar (1) · University Hospital, Caen (1) · University Hospital, Geneva (1) · University of Malaya (1)
Cambodia (1) · Cameroon (1) · France (1) · Guinea (1) · Malaysia (1) · Mozambique (1) · Switzerland (1) · Uganda (1) · United States (1) · Zambia (1)
Enos Bernasconi, MD (1) · Ghady Haidar, MD (1) · Laurent Kaiser, MD (1) · Maja Weisser, MD (1) · Vineya Rai Hakumat Rai (1)